CellaVision AB (publ)
CellaVision AB (publ) (CLVSF) Stock Overview
Explore CellaVision AB (publ)’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
459.8M
P/E Ratio
28.77
EPS (TTM)
$0.61
ROE
0.19%
CLVSF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CellaVision AB (publ) (CLVSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.71.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.77 and a market capitalization of 459.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.